This company has been marked as potentially delisted and may not be actively trading.

Talis Biomedical (TLIS) Competitors

TLIS vs. BNGO, MSAI, ASTC, STAI, and SMIT

Should you be buying Talis Biomedical stock or one of its competitors? The main competitors of Talis Biomedical include Bionano Genomics (BNGO), MultiSensor AI (MSAI), Astrotech (ASTC), ScanTech AI Systems (STAI), and Schmitt Industries (SMIT). These companies are all part of the "measuring and control equipment" industry.

How does Talis Biomedical compare to Bionano Genomics?

Bionano Genomics (NASDAQ:BNGO) and Talis Biomedical (NASDAQ:TLIS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends, media sentiment and earnings.

: In the previous week, Bionano Genomics had 5 more articles in the media than Talis Biomedical. MarketBeat recorded 5 mentions for Bionano Genomics and 0 mentions for Talis Biomedical. Bionano Genomics' average media sentiment score of 0.68 beat Talis Biomedical's score of 0.00 indicating that Bionano Genomics is being referred to more favorably in the media.
Company Overall Sentiment
Bionano Genomics Positive
Talis Biomedical Neutral
: Bionano Genomics presently has a consensus price target of $6.00, suggesting a potential upside of 359.77%. Given Bionano Genomics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Bionano Genomics is more favorable than Talis Biomedical.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bionano Genomics
1 Sell rating(s)
0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
Talis Biomedical
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: Bionano Genomics has higher revenue and earnings than Talis Biomedical. Bionano Genomics is trading at a lower price-to-earnings ratio than Talis Biomedical, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Bionano Genomics $28.51M 0.51 -$26.40M -$4.76 N/A
Talis Biomedical $300K 17.26 -$62.01M -$31.43 N/A
: Talis Biomedical has a net margin of 0.00% compared to Bionano Genomics' net margin of -92.59%. Bionano Genomics' return on equity of -56.22% beat Talis Biomedical's return on equity.
Company Net Margins Return on Equity Return on Assets
Bionano Genomics -92.59% -56.22% -34.38%
Talis Biomedical N/A -79.74% -57.16%
: 11.4% of Bionano Genomics shares are held by institutional investors. Comparatively, 43.8% of Talis Biomedical shares are held by institutional investors. 0.7% of Bionano Genomics shares are held by company insiders. Comparatively, 46.0% of Talis Biomedical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
: Bionano Genomics has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500. Comparatively, Talis Biomedical has a beta of 1.32, meaning that its stock price is 32% more volatile than the S&P 500.

Company	Overall Sentiment
Bionano Genomics	Positive
Talis Biomedical	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bionano Genomics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Talis Biomedical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bionano Genomics	$28.51M	0.51	-$26.40M	-$4.76	N/A
Talis Biomedical	$300K	17.26	-$62.01M	-$31.43	N/A

Company	Net Margins	Return on Equity	Return on Assets
Bionano Genomics	-92.59%	-56.22%	-34.38%
Talis Biomedical	N/A	-79.74%	-57.16%

Summary

Bionano Genomics beats Talis Biomedical on 11 of the 16 factors compared between the two stocks.

How does Talis Biomedical compare to MultiSensor AI?

Talis Biomedical (NASDAQ:TLIS) and MultiSensor AI (NASDAQ:MSAI) are both small-cap measuring and control equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

: Talis Biomedical has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, MultiSensor AI has a beta of -0.24, meaning that its share price is 124% less volatile than the S&P 500.
: 43.8% of Talis Biomedical shares are held by institutional investors. Comparatively, 82.3% of MultiSensor AI shares are held by institutional investors. 46.0% of Talis Biomedical shares are held by company insiders. Comparatively, 50.8% of MultiSensor AI shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
: MultiSensor AI has a consensus price target of $120.00, suggesting a potential upside of 1,911.74%. Given MultiSensor AI's stronger consensus rating and higher probable upside, analysts clearly believe MultiSensor AI is more favorable than Talis Biomedical.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Talis Biomedical
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
MultiSensor AI
1 Sell rating(s)

1 Hold rating(s)

0 Buy rating(s)

1 Strong Buy rating(s)
2.33
: Talis Biomedical has a net margin of 0.00% compared to MultiSensor AI's net margin of -211.01%. MultiSensor AI's return on equity of -74.39% beat Talis Biomedical's return on equity.
Company Net Margins Return on Equity Return on Assets
Talis Biomedical N/A -79.74% -57.16%
MultiSensor AI -211.01% -74.39% -59.77%
: MultiSensor AI has higher revenue and earnings than Talis Biomedical. MultiSensor AI is trading at a lower price-to-earnings ratio than Talis Biomedical, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Talis Biomedical $300K 17.26 -$62.01M -$31.43 N/A
MultiSensor AI $5.55M 2.16 -$11.71M -$12.80 N/A
: In the previous week, Talis Biomedical's average media sentiment score of 0.00 equaled MultiSensor AI'saverage media sentiment score.
Company Overall Sentiment
Talis Biomedical Neutral
MultiSensor AI Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Talis Biomedical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
MultiSensor AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

Company	Net Margins	Return on Equity	Return on Assets
Talis Biomedical	N/A	-79.74%	-57.16%
MultiSensor AI	-211.01%	-74.39%	-59.77%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Talis Biomedical	$300K	17.26	-$62.01M	-$31.43	N/A
MultiSensor AI	$5.55M	2.16	-$11.71M	-$12.80	N/A

Company	Overall Sentiment
Talis Biomedical	Neutral
MultiSensor AI	Neutral

Summary

MultiSensor AI beats Talis Biomedical on 9 of the 14 factors compared between the two stocks.

How does Talis Biomedical compare to Astrotech?

Astrotech (NASDAQ:ASTC) and Talis Biomedical (NASDAQ:TLIS) are both small-cap measuring and control equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

: Astrotech has a beta of -0.25, meaning that its share price is 125% less volatile than the S&P 500. Comparatively, Talis Biomedical has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500.
: Astrotech has higher revenue and earnings than Talis Biomedical. Astrotech is trading at a lower price-to-earnings ratio than Talis Biomedical, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Astrotech $1.05M 4.65 -$13.85M -$8.34 N/A
Talis Biomedical $300K 17.26 -$62.01M -$31.43 N/A
: In the previous week, Astrotech had 1 more articles in the media than Talis Biomedical. MarketBeat recorded 1 mentions for Astrotech and 0 mentions for Talis Biomedical. Astrotech's average media sentiment score of 0.00 equaled Talis Biomedical'saverage media sentiment score.
Company Overall Sentiment
Astrotech Neutral
Talis Biomedical Neutral
: 24.4% of Astrotech shares are owned by institutional investors. Comparatively, 43.8% of Talis Biomedical shares are owned by institutional investors. 16.8% of Astrotech shares are owned by insiders. Comparatively, 46.0% of Talis Biomedical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
: Talis Biomedical has a net margin of 0.00% compared to Astrotech's net margin of -1,163.89%. Astrotech's return on equity of -68.53% beat Talis Biomedical's return on equity.
Company Net Margins Return on Equity Return on Assets
Astrotech -1,163.89% -68.53% -57.30%
Talis Biomedical N/A -79.74% -57.16%
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Astrotech
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Talis Biomedical
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrotech	$1.05M	4.65	-$13.85M	-$8.34	N/A
Talis Biomedical	$300K	17.26	-$62.01M	-$31.43	N/A

Company	Overall Sentiment
Astrotech	Neutral
Talis Biomedical	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Astrotech	-1,163.89%	-68.53%	-57.30%
Talis Biomedical	N/A	-79.74%	-57.16%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Talis Biomedical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Talis Biomedical beats Astrotech on 7 of the 13 factors compared between the two stocks.

How does Talis Biomedical compare to ScanTech AI Systems?

ScanTech AI Systems (NASDAQ:STAI) and Talis Biomedical (NASDAQ:TLIS) are both small-cap measuring and control equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

: ScanTech AI Systems has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500. Comparatively, Talis Biomedical has a beta of 1.32, meaning that its stock price is 32% more volatile than the S&P 500.
: ScanTech AI Systems has higher revenue and earnings than Talis Biomedical. Talis Biomedical is trading at a lower price-to-earnings ratio than ScanTech AI Systems, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ScanTech AI Systems $1.88M 0.27 -$23.07M -$9.20 N/A
Talis Biomedical $300K 17.26 -$62.01M -$31.43 N/A
: In the previous week, ScanTech AI Systems' average media sentiment score of 0.00 equaled Talis Biomedical'saverage media sentiment score.
Company Overall Sentiment
ScanTech AI Systems Neutral
Talis Biomedical Neutral
: 74.0% of ScanTech AI Systems shares are owned by institutional investors. Comparatively, 43.8% of Talis Biomedical shares are owned by institutional investors. 2.3% of ScanTech AI Systems shares are owned by company insiders. Comparatively, 46.0% of Talis Biomedical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
: Talis Biomedical has a net margin of 0.00% compared to ScanTech AI Systems' net margin of -477.09%. ScanTech AI Systems' return on equity of -11.25% beat Talis Biomedical's return on equity.
Company Net Margins Return on Equity Return on Assets
ScanTech AI Systems -477.09% -11.25% 209.23%
Talis Biomedical N/A -79.74% -57.16%
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ScanTech AI Systems
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Talis Biomedical
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ScanTech AI Systems	$1.88M	0.27	-$23.07M	-$9.20	N/A
Talis Biomedical	$300K	17.26	-$62.01M	-$31.43	N/A

Company	Overall Sentiment
ScanTech AI Systems	Neutral
Talis Biomedical	Neutral

Company	Net Margins	Return on Equity	Return on Assets
ScanTech AI Systems	-477.09%	-11.25%	209.23%
Talis Biomedical	N/A	-79.74%	-57.16%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ScanTech AI Systems	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Talis Biomedical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

ScanTech AI Systems beats Talis Biomedical on 8 of the 12 factors compared between the two stocks.

How does Talis Biomedical compare to Schmitt Industries?

Talis Biomedical (NASDAQ:TLIS) and Schmitt Industries (NASDAQ:SMIT) are both small-cap measuring and control equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

: Talis Biomedical has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Comparatively, Schmitt Industries has a beta of -0.56, indicating that its share price is 156% less volatile than the S&P 500.
: 43.8% of Talis Biomedical shares are held by institutional investors. 46.0% of Talis Biomedical shares are held by company insiders. Comparatively, 17.1% of Schmitt Industries shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
: Schmitt Industries' return on equity of 0.00% beat Talis Biomedical's return on equity.
Company Net Margins Return on Equity Return on Assets
Talis Biomedical N/A -79.74% -57.16%
Schmitt Industries N/A N/A N/A
: Schmitt Industries has higher revenue and earnings than Talis Biomedical.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Talis Biomedical $300K 17.26 -$62.01M -$31.43 N/A
Schmitt Industries $9.89M 0.01 -$3.28M N/A N/A
: In the previous week, Schmitt Industries had 1 more articles in the media than Talis Biomedical. MarketBeat recorded 1 mentions for Schmitt Industries and 0 mentions for Talis Biomedical. Talis Biomedical's average media sentiment score of 0.00 equaled Schmitt Industries'average media sentiment score.
Company Overall Sentiment
Talis Biomedical Neutral
Schmitt Industries Neutral

Company	Net Margins	Return on Equity	Return on Assets
Talis Biomedical	N/A	-79.74%	-57.16%
Schmitt Industries	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Talis Biomedical	$300K	17.26	-$62.01M	-$31.43	N/A
Schmitt Industries	$9.89M	0.01	-$3.28M	N/A	N/A

Company	Overall Sentiment
Talis Biomedical	Neutral
Schmitt Industries	Neutral

Summary

Schmitt Industries beats Talis Biomedical on 5 of the 9 factors compared between the two stocks.

Get Talis Biomedical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLIS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TLIS vs. The Competition

Export

Metric	Talis Biomedical	Analytical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$5.18M	$92K	$6.20B	$12.23B
Dividend Yield	N/A	N/A	2.78%	5.25%
P/E Ratio	-0.10	N/A	28.72	27.04
Price / Sales	17.26	0.00	529.04	75.91
Price / Cash	N/A	N/A	43.30	53.97
Price / Book	0.07	0.36	9.85	6.85
Net Income	-$62.01M	-$47.72M	$3.55B	$333.00M

Talis Biomedical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TLIS Talis Biomedical	N/A	$2.84 flat	N/A	N/A	$5.18M	$300K	N/A	260
BNGO Bionano Genomics	2.5375 of 5 stars	$1.16 -2.5%	$6.00 +417.2%	-64.0%	$12.87M	$28.51M	N/A	300	News Coverage Upcoming Earnings
MSAI MultiSensor AI	2.6816 of 5 stars	$5.95 +9.8%	$120.00 +1,916.8%	-82.7%	$11.96M	$5.55M	N/A	35	Upcoming Earnings Gap Up High Trading Volume
ASTC Astrotech	0.7575 of 5 stars	$3.46 +2.4%	N/A	-52.3%	$6.09M	$1.05M	N/A	10	News Coverage Positive News Upcoming Earnings
STAI ScanTech AI Systems	N/A	$0.11 -2.2%	N/A	-99.7%	$619K	$1.88M	N/A	N/A	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TLIS) was last updated on 5/8/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Talis Biomedical (TLIS) Competitors

TLIS vs. BNGO, MSAI, ASTC, STAI, and SMIT

How does Talis Biomedical compare to Bionano Genomics?

Summary

How does Talis Biomedical compare to MultiSensor AI?

Summary

How does Talis Biomedical compare to Astrotech?

Summary

How does Talis Biomedical compare to ScanTech AI Systems?

Summary

How does Talis Biomedical compare to Schmitt Industries?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TLIS vs. The Competition

Talis Biomedical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Talis Biomedical (TLIS) Competitors

TLIS vs. BNGO, MSAI, ASTC, STAI, and SMIT

How does Talis Biomedical compare to Bionano Genomics?

Summary

How does Talis Biomedical compare to MultiSensor AI?

Summary

How does Talis Biomedical compare to Astrotech?

Summary

How does Talis Biomedical compare to ScanTech AI Systems?

Summary

How does Talis Biomedical compare to Schmitt Industries?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TLIS vs. The Competition

Talis Biomedical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools